Date post: | 01-Apr-2015 |
Category: |
Documents |
Upload: | rigoberto-loven |
View: | 218 times |
Download: | 2 times |
Invention for Innovation (i4i) Programme
Dr Martin Anyim
i4i Assistant Director
09/10/2013
To advance the translation of healthcare technologies for increased patient benefit through guided progression of
innovative medical technologies.
Programme objectives
Types of projects
A low-cost non-invasive visual aid for severely sight-impaired
individuals
Next Generation Mobile HIV Diagnostics with Wireless
Connectivity
Types of projects
Stroke reduction via improved opportunistic screening for atrial fibrillation - An evaluation of the clinical and economic benefits of the RapidRhythm device within
primary care
Facts and Figures
• Funding: £4 million in 2006/07; £20 million in 2013/14
• Projects last up to 3 years
• Current awards range from £170k up to £1.4 million but no formal limit
• Since 2010, 52 projects recommended for funding, totalling £31,105,714
Project team eligibility
• Must be collaborative - Minimum of two organisations
• NHS Trust, Higher Education Institution or industry
• SMEs are particularly welcome
• Lead applicants must be based in England or Wales only
3 key points...
• The benefits to patients and the NHS must be clearly articulated
• Applications must show a high degree of technological innovation
• The project team must contain the appropriate expertise for the work to be undertaken.
Application process
Stage 1 • Sift for eligibility• Assessed by Panel members
Sub-Panel• Includes Programme Director, Chairs and
Deputy Chairs• Shortlist to invite to Stage 2
Stage 2 • Peer review, including lay review• Due diligence begins
Panel• Risk friendly, multidisciplinary Panel• Presentations and Q&A
Selection criteria
• Demonstrable evidence that a novel technology or intervention will be the ultimate output of the research and will deliver benefits to patients
• Relevance of the research topic to the needs of the NHS and patients
• Strength of the research / management team
• The degree of technological innovation and the case for further development
• The health economic case
• The strength of the overall business/commercialisation plan
• The quality of the outline and full applications
2013 Calls – key dates
7th call for i4i Product Development AwardsCall opens 9 am, 20 November 2013Stage 1 closes 1 pm, 15 January 2014Panel meetings w/c 2 June 2014Outcome Late June 2014
8th call for i4i Product Development AwardsCall opens May 2014
3rd call for i4i Challenge AwardsTo be confirmed
Beyond the Panel• Due diligence
– Includes understanding IP position– Aimed at encouraging success
• Project milestones– All projects are contracted against milestones– Agreed with project team and CCF
• Monitoring– Active monitoring against milestones– Regular technical & financial reporting– Site visits, advice, RSGs, IPMG
Aim: To help health researchers maximise their chances of success when applying for funding and investment.
Eligibility: SMEs, academic researchers and clinicians applying to i4i or other medical-based funds, those seeking investment to take their early-stage products forward or to market.
Format: Four days and one evening intensive residential programme at Henley Business School.
Cost: £1750 per participant (excl VAT).
Next courses: the evening of Wednesday 9 to Friday 11 October and Monday 11 to Tuesday 12 November 2013.
Accelerator Programme Director, Ed Cooper
Tel: 0118 935 7115
Email: [email protected]
i4i Accelerator Programme
Website: www.i4i.nihr.ac.uk
Email: [email protected]
Tel: 020 8843 8015
NIHR CCF (i4i), Grange House, 15 Church Street, Twickenham, TW1 3NL
Contact details